Jiangsu Hengrui Medicine (600276.SS) - EPS (earnings per share)

EPS in 2026 (TTM): S$0.19

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.19. In 2025 the company made an earnings per share (EPS) of S$0.22 an increase over its 2024 EPS that were of S$0.18.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	S$0.19	-11.28%
2025	S$0.22	24.14%
2024	S$0.18	42.43%
2023	S$0.12	8.77%
2022	S$0.11	-20.62%
2021	S$0.14	-26.59%
2020	S$0.20	27.24%
2019	S$0.15	28.41%
2018	S$0.12	20.04%
2017	S$0.09993	31.21%
2016	S$0.07616	11.46%
2015	S$0.06833	36.27%
2014	S$0.05014	19.77%
2013	S$0.04187	18.05%
2012	S$0.03546	23.9%
2011	S$0.02862	26.9%
2010	S$0.02256	12.37%
2009	S$0.02007	56.6%
2008	S$0.01282	9.18%
2007	S$0.01174	114.48%
2006	S$0.005474	64.83%
2005	S$0.003321	35.55%
2004	S$0.002450	29.73%
2003	S$0.001889	19.86%
2002	S$0.001576	-2.71%
2001	S$0.001620	1.02%
2000	S$0.001603

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Jiangsu Hengrui Medicine (600276.SS)